Showing results (671-680 of 9,402) with videos related to

Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|April 1, 1987
Dynamic exercise-induced increase in lymphocyte beta-2-adrenoceptors: abnormality in essential hypertension and its correction by antihypertensivesO E Brodde, A E Daul, X L Wang, et al.
Clinical Pharmacology and Therapeutics|June 15, 2019
Prediction of the Impact of Cytochrome P450 2C9 Genotypes on the Drug-Drug Interaction Potential of Siponimod With Physiologically-Based Pharmacokinetic Modeling: A Comprehensive Approach for Drug Label RecommendationsFelix Huth, Anne Gardin, Kenichi Umehara, et al.
Clinical Pharmacology and Therapeutics|June 18, 2019
N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's DiseaseDaniel A Monti, George Zabrecky, Daniel Kremens, et al.
Clinical Pharmacology and Therapeutics|September 12, 2018
Patient-Focused Drug Development Methods for Benefit-Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic DrugsEmily A F Holmes, Catrin Plumpton, Gus A Baker, et al.
Clinical Pharmacology and Therapeutics|September 5, 2018
Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?Hans-Georg Eichler, Brigitte Bloechl-Daum, Karl Broich, et al.
Clinical Pharmacology and Therapeutics|November 1, 1985
Effect of naloxone on the actions of captoprilA A Ajayi, B C Campbell, P C Rubin, et al.
Clinical Pharmacology and Therapeutics|September 1, 1987
Variable glyceryl dinitrate formation as a function of route of nitroglycerin administrationP K Noonan, L Z Benet
Clinical Pharmacology and Therapeutics|May 18, 2019
Modulation of CYP450 Activities in Patients With Type 2 DiabetesSophie Gravel, Jean-Louis Chiasson, Jacques Turgeon, et al.
Clinical Pharmacology and Therapeutics|May 1, 2019
The Advantages and Challenges of Diversity in Pharmacogenomics: Can Minority Populations Bring Us Closer to Implementation?Honghong Zhang, Tanima De, Yizhen Zhong, et al.
Clinical Pharmacology and Therapeutics|April 18, 2019
Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and AdultsJanneke M Brussee, Jessica D Schulz, Jean T Coulibaly, et al.
Pageof 941